Is antithrombin III for sepsis-associated disseminated intravascular coagulation really ineffective?

被引：4

作者：

Iba, Toshiaki ^{[1
]}

Thachil, Jecko ^{[2
]}

机构：

[1] Juntendo Univ, Dept Emergency & Disaster Med, Grad Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan

[2] Manchester Royal Infirm, Dept Haematol, Oxford Rd, Manchester M13 9WL, Lancs, England

来源：

INTENSIVE CARE MEDICINE | 2016年 / 42卷 / 07期

关键词：

TRIAL;

D O I：

10.1007/s00134-016-4288-5

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：1193 / 1194

页数：2

共 5 条

[1] Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis [J].

Allingstrup, Mikkel ;

Wetterslev, Jorn ;

Ravn, Frederikke B. ;

Moller, Ann Merete ;

Afshari, Arash .

INTENSIVE CARE MEDICINE, 2016, 42 (04) :505-520

[2] Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation [J].

Kienast, J ;

Juers, M ;

Wiedermann, CJ ;

Hoffmann, JN ;

Ostermann, H ;

Strauss, R ;

Keinecke, HO ;

Warren, BL ;

Opal, SM .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (01) :90-97

[3] Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study [J].

Tagami, T. ;

Matsui, H. ;

Horiguchi, H. ;

Fushimi, K. ;

Yasunaga, H. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (09) :1470-1479

[4]

Umemura Y, 2015, J THROMB HAEMOST, V13, P1

[5] High-dose a randomized antithrombin III in severe sepsis -: A randomized controlled trial [J].

Warren, BL ;

Eid, A ;

Singer, P ;

Pillay, SS ;

Carl, P ;

Novak, I ;

Chalupa, P ;

Atherstone, A ;

Pénzes, I ;

Kübler, A ;

Knaub, S ;

Keinecke, HO ;

Heinrichs, H ;

Schindel, F ;

Juers, M ;

Bone, RC ;

Opal, SM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (15) :1869-1878

← 1 →